|
|
 The
Cancersafe® test range are highly sophisticated
tests that detects cancer ‘tumour markers’
early and before a tumour becomes malignant.
If you are concerned about Lung Cancer, Ovarian
Cancer, Breast Cancer or any other Cancer, the
Cancersafe test is the perfect test for you.
Early detection of cancer is important. if cancer
is detected in early stage it is curable. This
can save your life or at least allows you to get
a baseline for the future. In order to cover a
large range of cancers (the main ones), the CancersafeŽ
test range of tests incorporate the main tumor
markers detected worldwide.
The
test can look for signs of various cancers like:
The Cancersafe® (comprehensive) test detects
a panel of 10/11 tumor markers (10 for women,
11 for men). Each of these tumour markers has
shown affiliations to one or more type of cancers.
The panel
for women : CEA, CA 15-3, CA 19-9, CA
125, CA 72-4, AFP, BHCG, B2M, NSE, CYFRA 21-1.
The panel for men :
CEA, CA 19-9, CA 125, CA 72-4, PSA+FPSA, AFP,
BHCG, B2M, NSE, CYFRA 21-1.
- Fill in the Test Request form by clicking
on the ‘Test Request’ button next
to a test.
- A staff from Eastern Biotech will contact
you and provide all necessary information.
- An appointment with the nearest medical
test centre will be arranged for you
to deliver your blood sample.
- Payment for each test can be made at the
test centre
- Your sample will be processed at our affiliate
laboratory and the report will be delivered
to you by email and also by post.
|
|
|
 |
| |
|
 |
| Smoker®
Test |
 |
| Ovarian
Safe® Test |
|
| Breast Safe® Test |
|
| Colon Safe® Test |
|
Cancer Safe®Test
(comprehensive) |
|
|
|
What is Smoker
® Test?
The Smoker ® Test is a sophisticated
test which can be useful in detecting lung
cancer, and recurrences of lung cancer,
before clinical signals appear. Early detection
can lead to a cure and can help to increase
the overall health of clients by enhancing
and promoting health, wellness, and quality
of life.
Why
should you do Smoker ® Test?
One should undergo Smoker ® Test to
detect lung cancers before the appearance
of any clinical or radiological signs. People
who should take the test regularly are:
- Heavy smokers because they are far
more likely than the non-smokers to
develop diseases such as lung cancer.
- People who are exposed to radon gases,
asbestos and certain chemicals like
vinyl chloride, nickel chromates and
coal products.
- People exposed to second hand smoking.
- People having hereditary risk of
developing cancer.
What is Ovarian
Safe® Test?
Cancersafe produces a new form of screening
for detecting ovarian cancers. Ovarian cancer
is often called a "silent killer"
because many times there are no symptoms
untill the disease has progressed to an
advanced stage. Early symptoms of ovarian
cancer are often mild, making this disease
difficult to detect.
Why
do Ovarian Safe® Test?
People who should take this test to detect
and monitor the development of ovarian cancers
regularly are:
- People who have relatives (grandmother,
mother, sisters, aunts) on either your
mother's or father's side of the family
who had breast cancer diagnosed before
age 50
- There is both breast and ovarian
cancer in one’s family, particularly
in a single individual.
- Women in the family have had cancer
in both breasts.
- People belonging to Ashkenazi Jewish
family (family from Eastern European).
- A man in the family has had breast
cancer.
What is Breast
SafeŽTest? A new breast cancer
detection test helps people to identify
cancer at a very early stage which can help
to treat the disease on time and thus can
be cured completely.
Why
do Breast SafeŽ Test? People who
should undergo this screening process are:
- People who have blood relatives (grandmother,
mother, sisters, aunts) on either your
mother's or father's side of the family
who had breast cancer diagnosed before
age 50
- There is both breast and ovarian
cancer in one's family, particularly
in a single individual.
- Women in the family have had cancer
in both breast.
- People belonging to Ashkenazi Jewish
family (family from Eastern European).
- A man in the family has had breast
cancer.
What is a Colon Safe®Test?
The ColonSafe test is developed to detect
colon polyps or growth long before it eventually
becomes cancerous.
Why
do a Colon Safe® Test?
People should go for screening of the colon
once a year. People having blood relatives
on either your mother’s or father’s
side of the family who suffered from colon
cancer are at increased risk of developing
it themselves. One of the strongest risk
factors for colon cancer is age. Besides
this, smokers, drinkers, sedentary and obese
persons are more likely to develop colon
cancers.
Test What is CancersafeŽ
(comprehensive) test?
It is a highly sophisticated test to detect
early cancer. Tumor markers have long been
used, either to screen for cancers or to
monitor cancer treatments, to track and
screen for recurrences. CancersafeŽ test
uses a panel of 10/11 tumor markers (10
for women, 11 for men). Tumor markers are
molecules that appear in relation to development
of some of the most important cancers. Measurement
or identification of tumor markers is useful,
because it can detect substances at early
stages indicating that further medical attention
is needed.
CancersafeŽ test can also be useful in follow-up
if you are being treated for the illness.
Variations of the tumor markers can be followed
by regular tests. Slight to moderate increase
may occur 6-12 months before clinical signs
of relapse.
Who should perform the test?
For early diagnosis, everybody should take
the CancerSafe (comprehensive test), however
certain high risk groups such as persons
over 40 years of age and young women concerned
about breast and ovarian cancer.
The Cancersafe (comprehensive)
panel should be performed at least
once a year, or more if required, building
your baseline and data for future: your
report (since handling all results) will
include graphs, demonstrating the evolution
of the 10 (or 11) tumor markers: any abnormal
increases would be an indication for medical
consultation and further investigation.
Testing Options
- Panel for Women
- Panel for Men
Panel for Women
The result includes graphs demonstrating
the evolution of the following tumor markers.
This evolution should be highly considered
for treatment and prognosis if the possibility
of developing cancer is observed.
CEA, CA15-3, CA19-9, CA125, CA72-4, AFP,
BHCG, B2M, NSE, CYFRA21-1 "
Panel for Men
All men, over 40, should perform it once
a year, or more if required. This panel
covers a wide range of cancers which are
common in men. The evolution of the following
tumor markers are demonstrated to screen
for developing cancers in men.
CEA, CA19-9, CA125, CA72-4, PSA+ FPSA, AFP,
BHCG, B2M, NSE, CYFRA 21-1
|
|
|
|
| |
|
